Description
Track study progress, view treatment schedules, and receive reminders for medication and appointments. Access study documents, report adverse events, and communicate with study coordinators. Monitor health metrics and view lab results.
A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination with Standard of Care Immunotherapy in Participants with Resected or Unresectable KRAS G12C-Mutant, Non-Small Cell Lung Cancer - SUNRAY-02. This app is specifically intended for participants in the J3M-MC-JZQH study only.